GC-PRO Intervention

NCT ID: NCT06671704

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

994 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-03

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the GC-PRO study is to try to make genetic counseling better for people of all backgrounds. We are asking participants to complete two surveys and to allow audio recording of their genetic counseling visit. The purpose of the study is to understand whether trying different ways of doing genetic counseling will lead to better experiences for patients. The research team is also working with partners from the Somali, Latino/Hispanic, Black/African American, and Hmong communities to make sure the research is being done in a way that will benefit underserved communities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Cardiovascular Diseases Prenatal Condition Reproductive Condition Genetic Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Stepped wedge randomized controlled trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cluster 1

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 4-15

Group Type EXPERIMENTAL

Genetic counseling months 4-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 4 to month 15.

Cluster 2

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 6-15

Group Type EXPERIMENTAL

Genetic counseling months 6-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 6 to month 15.

Cluster 3

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 8-15

Group Type EXPERIMENTAL

Genetic counseling months 8-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 8 to month 15.

Cluster 4

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 10-15

Group Type EXPERIMENTAL

Genetic counseling at months 10-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 10 to month 15.

Cluster 5

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 12-15

Group Type EXPERIMENTAL

Genetic counseling at months 12-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 12 to month 15.

Cluster 6

Patients recruited and randomized to transfer from standard of care to genetic counselling in months 14-15

Group Type EXPERIMENTAL

Genetic counseling at months 14-15

Intervention Type OTHER

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 14 to month 15.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Genetic counseling months 4-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 4 to month 15.

Intervention Type OTHER

Genetic counseling months 6-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 6 to month 15.

Intervention Type OTHER

Genetic counseling months 8-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 8 to month 15.

Intervention Type OTHER

Genetic counseling at months 10-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 10 to month 15.

Intervention Type OTHER

Genetic counseling at months 12-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 12 to month 15.

Intervention Type OTHER

Genetic counseling at months 14-15

all genetic counselors within the same specialty at the same site will cross over from standard of care to the intervention training starting at month 14 to month 15.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 years or older
* individual OR their child has been referred to genetic counseling for family and/or personal history of hereditary cancer, cardiology condition, general genetics indication, or reproductive/prenatal indication at a participating study site
* understand and be able to provide information for study forms and surveys in English.

Exclusion Criteria

* Unable to provide informed consent
* For pediatric genetic counseling referrals, individuals who are not the parent or legal guardian of the child will be excluded from participating.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of South Florida

OTHER

Sponsor Role collaborator

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heather Zierhut

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elena Fisher

Role: CONTACT

612-626-6743

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elena Fischer

Role: primary

612-626-6743

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CBS-2024-33212

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Omics Gaucher Study: Multiomic Approach
NCT05526664 ACTIVE_NOT_RECRUITING